Some AR antagonists reduce the translocation of the ligand-bound-AR complex into the nucleus and/or inhibit the recruitment of transcriptional co-activators resulting in inhibition of the AR-mediated gene transactivation [15] and finally, leading to repression of PCa growth [11,16,17]. Here, AR is linked to posterior cortical atrophy.